International Clinical Trial: An exploratory single-arm trial of tirofiban adjuvant therapy after intravenous thrombolysis with reteplase

Geneva, June 22 -- International Clinical Trials Registry received information related to the study (ChiCTR2600126685) titled 'An exploratory single-arm trial of tirofiban adjuvant therapy after intravenous thrombolysis with reteplase' on June 13.

Study Type: Interventional study

Study Design: Single arm

Primary Sponsor: Pingshan District People's Hospital of Shenzhen

Condition: cute ischemic stroke

Intervention: Experimental group:Thrombolytic Therapy All enrolled patients received standard intravenous reteplase thrombolysis (two 18-mg intravenous boluses administered 30 minutes apart). Intervention: Tirofiban infusion was initiated within 4-24 hours after reteplase thrombolysis

Recruitment Status: Not Recruiting

Phase: 4

Da...